Department of Internal Medicine, Madigan Army Medical Center, Joint Base Lewis-McChord, WA 98431, USA.
Mil Med. 2021 Aug 28;186(9-10):e1053-e1057. doi: 10.1093/milmed/usab100.
We report the case of a 52-year-old white male who was recently diagnosed with symptomatic coronavirus disease-2019 (COVID-19) and presented to the hospital with ventricular tachycardia/ventricular fibrillation cardiac arrest, ST elevation myocardial infarction, and profound hypokalemia. The patient was successfully treated with primary percutaneous coronary intervention and concurrent aggressive potassium repletion. To the authors' knowledge, this is the first case of COVID-19 presenting not only with an acute coronary thrombosis but also severe hypokalemia, both of which contributed to his cardiac arrest. The association of COVID-19 with acute coronary thrombosis, including the challenges surrounding the diagnosis and management in this patient population, is discussed. Additionally, the effect of COVID-19 on the renin-angiotensin-aldosterone system is reviewed with a focus on hypokalemic presentations.
我们报告了一例 52 岁的白人男性病例,他最近被诊断出患有有症状的 2019 年冠状病毒病(COVID-19),并因室性心动过速/心室颤动性心脏骤停、ST 段抬高型心肌梗死和严重低钾血症而到医院就诊。患者经初步经皮冠状动脉介入治疗和同时进行的积极补钾治疗后成功救治。据作者所知,这是首例不仅表现出急性冠状动脉血栓形成,而且还表现出严重低钾血症的 COVID-19 病例,这两者均导致了他的心脏骤停。讨论了 COVID-19 与急性冠状动脉血栓形成之间的关联,包括在该患者人群中诊断和管理方面所面临的挑战。此外,还回顾了 COVID-19 对肾素-血管紧张素-醛固酮系统的影响,重点讨论了低钾血症的表现。